The Domestic Surgical Robot Application Development Forum Was Held in Guangzhou.
The Domestic Surgical Robot Application Development Forum was held in Guangzhou. Xie Jing, the CTO of WeMed Medical, was invited to attend and gave a speech. He was talking about the development of surgical robots and interventional robots, and detailed the direction of clinical development of surgical robots. During the speech, Mr. Xie gave a comprehensive introduction about WeMed Medical’s interventional robot--ET cath. the clinical application, software and hardware composition.
The topic of the forum is about the development status and main problems of domestic surgical robots. The invited companies for this conference are all innovative companies with great achievements and pioneering spirit in the field of surgical robots. Clinical experts, outstanding corporate representatives, and senior investors gathered together to discuss topics in the field of robotics from multiple perspectives and in all directions. The content covers the research and development, clinical application, and market prospects of surgical robots.
As an outstanding representative of the national high-end medical brand. The development strategy of WeMed Medical is highly consistent with the theme of this BFA Annual Conference 2022. WeMed Medical is deeply engaged in the field of interventional medicine, focusing on the provision of interventional diagnosis and treatment equipment and full-process solutions. With years of experience in R&D, design, and industrialization of digital vascular imaging products, the products cover a number of interventional product lines such as Digital Subtraction Angiography System, Mobile Angiography System, Mobile C arm X-Ray System, and Interventional Robot.
Adhering to the concept of "Innovation for Health", creating brand new domestic products. It is worth mentioning that in the field of vascular interventional robots, WeMed Medical has achieved many technological breakthroughs. The ETcath vascular intervention robot, which is completely domestically developed and independently developed, has obtained more than 100 international and domestic patents. Occupy the technical high ground of interventional robots and take the leading position in the global interventional robot industry.
The mission of WeMed Medical is to create a new pattern of interventional medicine, build the future of interventional imaging, and become an important force in China to promote the development of the global medical field.
